Patricia Gao, MD
Internal Medicine · Glen Burnie, MDNPI 1821070608
Payments from drug & device makers
Across 163 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$568
- Novo Nordisk$510
- Boehringer Ingelheim$390
- Lilly USA, LLC$304
- GSK$169
- Astellas Pharma US Inc$110
- plus $694 from 17 others
What the payments were for
- Food & beverage$2,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $568 |
| Novo Nordisk | 35 | $510 |
| Boehringer Ingelheim | 22 | $390 |
| Lilly USA, LLC | 17 | $304 |
| GSK | 10 | $169 |
| Astellas Pharma US Inc | 6 | $110 |
| Pfizer | 6 | $103 |
| Amgen(2 entities) | 6 | $94 |
| Amarin Pharma, Inc. | 5 | $92 |
| Merck | 4 | $72 |
| Bayer | 3 | $69 |
| Dexcom, Inc. | 1 | $32 |
| Corium, LLC | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Radius Health, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Abbott | 1 | $16 |
| AbbVie | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Exact Sciences | 1 | $16 |
How this compares
$2,744 in reported general payments places this provider in the 80th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 60 | $930 |
| Atorvastatin Calcium | 63 | $757 |
| Levothyroxine Sodium | 31 | $726 |
| Metoprolol Succinate | 24 | $631 |
| Rosuvastatin Calcium | 22 | $569 |
| Pravastatin Sodium | 21 | $451 |
| Amlodipine Besylate | 53 | $423 |
| Bupropion XlBupropion Hcl | 12 | $388 |
| Lisinopril | 37 | $367 |
| Hydralazine Hcl | 14 | $344 |
| Alendronate Sodium | 19 | $180 |
| Pantoprazole Sodium | 11 | $138 |
| Metformin Hcl | 14 | $95 |
| Hydrochlorothiazide | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Glen Burnie
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Rahul PatelRockville$2.8M
- Mark YarchoanBaltimore$2.4M
- Marianne MannHighland$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.